T

The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)

Speaking in the House of Lords on 12 October 2026

Debate

Weight-loss Drugs

Contribution

My Lords, weight-loss medicines are considered through the established MHRA and NICE processes, which ensure that they are used routinely for NHS patients only following an assessment of their safety, effectiveness and value for money. Patients’ safety remains paramount. These prescription-only medicines should be prescribed following appropriate clinical assessment, with ongoing monitoring and behavioural support, and obtained only from regulated providers and pharmacies.

More from The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.